Cellectis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!

About CLLS

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. 

CEO
André Choulika
CEOAndré Choulika
Employees
222
Employees222
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
2000
Founded2000
Employees
222
Employees222

CLLS Key Statistics

Market cap
268.34M
Market cap268.34M
Price-Earnings ratio
-10.79
Price-Earnings ratio-10.79
Dividend yield
—
Dividend yield—
Average volume
57.25K
Average volume57.25K
High today
$3.78
High today$3.78
Low today
$3.52
Low today$3.52
Open price
$3.59
Open price$3.59
Volume
165.97K
Volume165.97K
52 Week high
$5.48
52 Week high$5.48
52 Week low
$1.10
52 Week low$1.10

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.